Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
April 4, 2007

Pfizer and pSivida Ink $165M Deal

  • Pfizer gained access to pSivida's controlled drug delivery technologies, including the Medidur™ technology in ophthalmic applications.

    Under this exclusive, worldwide CRADA, pSivida stands to earn $155 million in development and sales related milestones. Pfizer will fund the total cost of the joint research program aimed at developing products using pSivida’s technologies.

    Pfizer also reports that it invested $5 million in pSivida and plans to contribute an additional $5 million subject to certain conditions.

  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.